Grufity logoGrufity logo

MED

120.48USD+0.31(+0.26%)Market Closed

Medifast Inc

Market Summary

USD120.48+0.31Market Closed
0.26%

MED Alerts

MED Stock Price

RSI Chart

Valuation

Market Cap

1.3B

Price/Earnings

8.24

Price/Sales

0.78

Price/Cashflow

13.51

MarketCap/EBT

6.29

Price/Sales

Profitability

Operating Margin

72.76%

EBT Margin

12.38%

Return on Equity

121.18%

Return on Assets

46.07%

Fundamentals

Revenue

Revenue (TTM)

1.7B

Revenue Y/Y

15%

Revenue Q/Q

8.56%

Earnings

Earnings (TTM)

156.9M

Earnings Y/Y

-16.72%

Earnings Q/Q

-6.39%

Price Action

52 Week Range

96.00217.97
(Low)(High)

Last 7 days

-0.4%

Last 30 days

2.6%

Last 90 days

-5.2%

Trailing 12 Months

-41.4%

Financial Health

Current Ratio

1.29

Investor Care

Dividend Yield

5.21%

Dividend/Share (TTM)

6.12

Buy Backs (1Y)

6.07%

Diluted EPS (TTM)

13.48

Peers (Alternatives to Medifast)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
320.4B
80.5B
8.42% 1.88%
21.99
3.98
4.31% 3.03%
72.2B
17.3B
5.26% -34.59%
29.98
4.07
1.35% -16.24%
62.3B
17.7B
2.33% 1.52%
32.33
3.51
2.30% -27.65%
42.0B
20.2B
7.27% 1.17%
23.52
2.08
5.04% -10.62%
18.2B
7.0B
0.60% -11.78%
39.49
2.57
-2.63% -7.32%
MID-CAP
5.6B
5.3B
10.85% -22.61%
21.76
1.06
9.13% 182.41%
3.3B
1.4B
0.04% 13.88%
57.07
2.5
9.98% 198.19%
2.6B
986.6M
13.04% 9.57%
25.86
2.67
15.68% -0.25%
2.3B
417.7M
26.61% 78.56%
82.15
5.5
19.13% 115.17%
2.1B
2.2B
3.82% -1.77%
19.02
0.95
4.04% -15.73%
SMALL-CAP
1.3B
1.7B
2.62% -41.45%
8.24
0.78
30.75% 4.27%
1.1B
1.0B
-3.46% -46.38%
11.88
0.98
-15.59% -43.40%
214.8M
-
-40.09% -62.17%
-0.56
0.1
- -7.75%
64.0M
13.6M
-17.23% -26.25%
17.4
4.46
7.56% -27.60%
51.8M
175.8M
-12.30% -42.98%
4.84
0.3
-0.78% -27.68%

Financials for Medifast

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q22022Q12021Q42021Q32021Q2
Revenue3.7%1,6621,6031,5261,4131,271
Cost Of Revenue7.4%453422398365326
Gross Profit2.4%1,2091,1811,1281,049946
  S&GA Expenses4.2%1,003963911841749
Earnings Before Taxes-5.7%206218216207197
Net Income-4.8%157165164158150
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q22022Q12021Q42021Q32021Q2
Assets-19.2%341421398371364
  Current Assets-25.0%243324307301304
    Cash Equivalents-48.2%61118104155192
  Inventory-16.9%15718918013096
  Net PPE1.3%5958564637
Liabilities2.8%211205196175170
  Current Liabilities3.9%188181170161154
Shareholder's Equity-40.1%129216202196195
  Retained Earnings-36.4%129203190183185
  Additional Paid-In Capital-100.0%-13121311
Shares Outstanding-4.6%1112121212
Float-3,300----
* denotes actual numbers (not divided by Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q22022Q12021Q42021Q32021Q2
Cashflow From Operations31.4%967395122147
  Share Based Compensation7.7%11101099
Cashflow From Investing24.6%-22.59-29.95-29.06-16.87-8.75
Cashflow From Financing-55.9%-204.32-131.03-125.13-107.04-77.29
  Dividend Payments3.4%6967646057
  Buy Backs133.0%13658564620

Risks

What is the probability of a big loss on MED?

82.3%


Probability that Medifast stock will be more than 20% underwater in next one year

73.1%


Probability that Medifast stock will be more than 30% underwater in next one year.

67.7%


Probability that Medifast stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does MED drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Medifast was unfortunately bought at previous high price.

Returns

Cumulative Returns on MED

16.5%


10-Year Cumulative Returns

25.2%


7-Year Cumulative Returns

14.9%


5-Year Cumulative Returns

14.5%


3-Year Cumulative Returns

What are the long-term rolling returns for MED?

FIve years rolling returns for Medifast.

Which funds bought or sold MED recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-23
Aurora Investment Counsel
REDUCED
-51.52
-1,274,000
544,000
0.41%
2022-11-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
NEW
-
496,000
496,000
0.01%
2022-11-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
REDUCED
-3.72
-1,124,000
1,539,000
-%
2022-11-16
CAPTRUST FINANCIAL ADVISORS
SOLD OFF
-100
-138,000
-
-%
2022-11-15
JACOBS LEVY EQUITY MANAGEMENT, INC
ADDED
84.25
602,000
6,272,000
0.05%
2022-11-15
ALLIANCEBERNSTEIN L.P.
REDUCED
-11.4
-1,672,000
1,901,000
-%
2022-11-15
Laurel Wealth Advisors LLC
SOLD OFF
-100
-1,000
-
-%
2022-11-15
HARBOUR INVESTMENTS, INC.
UNCHANGED
-
-
46,000
-%
2022-11-15
ALGERT GLOBAL LLC
ADDED
0.23
-1,428,000
2,155,000
0.13%
2022-11-15
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO
ADDED
19.08
-17,000
42,000
-%

1–10 of 45

Latest Funds Activity

Are funds buying MED calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own MED

Medifast News

ETF Daily News

Mackenzie Financial Corp Invests $216000 in Medifast, Inc. (NYSE:MED).69 minutes ago

MED Fair Value

Medifast fair value in different scenarios

The table shows the Fair Value estimates for Medifast for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

433.52

259.83%

934.91

675.99%

1523.78

1164.76%

2127.94

1666.22%

2522.19

1993.45%

Current Inflation

393.76

226.83%

827.93

587.19%

1319.79

995.44%

1831.37

1420.06%

2161.46

1694.04%

Very High Inflation

345.00

186.35%

700.52

481.44%

1082.97

798.88%

1489.22

1136.07%

1747.42

1350.38%

Historical Medifast Fair Value Estimates


Recent SEC filings of Medifast

View All Filings
Date Filed Form Type Document
Nov 10, 2022
4
Insider Trading
Nov 10, 2022
4
Insider Trading
Nov 10, 2022
4
Insider Trading
Nov 10, 2022
4
Insider Trading
Nov 10, 2022
4
Insider Trading
Nov 03, 2022
8-K
Current Report
Nov 03, 2022
10-Q
Quarterly Report
Sep 08, 2022
8-K
Current Report

Latest Insider Trading transactions for MED

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-11-08
HALLQUIST CONSTANCE J.
BOUGHT
1,126.72
106.93
10.537
-
2022-11-08
Thomas Andrea B
BOUGHT
1,093.57
106.93
10.227
-
2022-11-08
BROWN JEFFREY J
BOUGHT
1,269.47
106.93
11.872
-
2022-11-08
Hoer Michael A.
BOUGHT
1,078.6
106.93
10.087
-
2022-11-08
SCHLACKMAN SCOTT
BOUGHT
1,110.15
106.93
10.382
-
2022-11-04
BROWN JEFFREY J
BOUGHT
58,935.7
105.06
560.972
-
2022-08-09
BROWN JEFFREY J
BOUGHT
498,549
126.535
3,940
-
2022-08-08
Hoer Michael A.
ACQUIRED
1,065.97
138.78
7.681
-
2022-08-08
BROWN JEFFREY J
ACQUIRED
1,254.57
138.78
9.04
-
2022-08-08
HALLQUIST CONSTANCE J.
ACQUIRED
1,113.57
138.78
8.024
-

1–10 of 50

Daniel R. Chard
980
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland.

MED Income Statement

2022-09-30
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]    
Revenue$ 390,398$ 413,395$ 1,261,332$ 1,148,253
Cost of sales107,549106,338354,515298,942
Gross profit282,849307,057906,817849,311
Selling, general, and administrative234,693251,886754,610679,907
Income from operations48,15655,171152,207169,404
Other income (expense)    
Interest expense(261)(94)(519)(138)
Other income (expense)(17)115(37)112
Total other (expense) income(278)21(556)(26)
Income from operations before income taxes47,87855,192151,651169,378
Provision for income taxes11,72313,21034,60139,370
Net income$ 36,155$ 41,982$ 117,050$ 130,008
Basic earnings per share    
Earnings per share - basic (in dollars per share)$ 3.30$ 3.59$ 10.37$ 11.07
Diluted earnings per share    
Earnings per share - diluted (in dollars per share)$ 3.27$ 3.56$ 10.30$ 10.98
Weighted average shares outstanding -    
Basic (in shares)10,96411,69211,29011,739
Diluted (in shares)11,04211,78511,36911,840
Cash dividends declared per share (in dollars per share)$ 1.64$ 1.42$ 4.92$ 4.26

MED Balance Sheet

2022-09-30
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current Assets  
Cash and cash equivalents$ 69,710$ 104,183
Inventories145,279180,043
Investment securities05,361
Income taxes, prepaid150945
Prepaid expenses and other current assets14,44516,334
Total current assets229,584306,866
Property, plant and equipment - net of accumulated depreciation58,10756,131
Right-of-use assets19,81924,457
Other assets12,6916,468
Deferred tax assets6,1504,404
TOTAL ASSETS326,351398,326
Current Liabilities  
Accounts payable and accrued expenses148,129163,309
Revolving credit facility00
Current lease obligations6,1266,523
Total current liabilities154,255169,832
Lease obligations, net of current lease obligations21,57426,020
Total liabilities175,829195,852
Stockholders' Equity  
Common stock, par value $0.001 per share: 20,000 shares authorized; 10,929 and 11,594 issued and 10,928 and 11,593 outstanding at September 30, 2022 and December 31, 2021, respectively1112
Additional paid-in capital18,61712,018
Accumulated other comprehensive income391111
Retained earnings131,503190,333
Total stockholders' equity150,522202,474
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY$ 326,351$ 398,326